In vivo studies were also performed, showing larger amounts of ATP secretion and calreticulin translocation in tumor tissue from the treatment group as well as higher concentrations of TNF-α and IFN-γ in serum taken from treated mice. The gene discussed is IFNG; the disease is neoplasm.